Costa Rica vs India: Share of children with symptoms of a respiratory infection who received antibiotics
Costa Rica
67.3%
in 2018
India
66.8%
in 2018
Costa Rica rank
23rd
India rank
25th
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Costa Rica
- India
How they compare
Costa Rica currently reports 67.3% against 66.8% in India, a difference of 0.5%.
The two have swapped places 4 times across 19 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 23rd and India ranks 25th of 132 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.0% | 51.1% | 17.0% | Costa Rica |
| 2010s | 67.3% | 64.5% | 2.7% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Costa Rica or India?
- Costa Rica, at 67.3% against 66.8% in India as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Costa Rica and India?
- 0.5%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and India?
- 19 years are reported by both, from 2000 to 2018.
- How do Costa Rica and India rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Costa Rica ranks 23rd and India ranks 25th of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.